Martin Manninger

Jul 31, 2023 | mdpi.com | Ursula Rohrer |Martin Manninger |Lukas Fiedler |Clemens Steinwender

4. DiscussionThe VEST trial did not show a significant reduction in arrhythmic mortality in WCD patients after AMI, with a lower-than-expected compliance as one possible explanation. We compared these results to data from a well-compliant real-world population and demonstrated that shock rates and arrhythmic mortality were similar to those in the VEST trial, despite good WCD compliance.